2026 David A. Ostrov: Biology and Biochemistry Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Biology and Biochemistry	53	16298	14968	6749	6034	243	8810

Overview

David A. Ostrov is affiliated with the University of Florida in the United States. Their research focuses primarily on Medicine, with significant contributions in Biochemistry, Genetics, and Molecular Biology. The subfields of their work include Infectious Diseases, Molecular Biology, Immunology, Oncology, and Pharmacology.

The scientist's recent publications cover a range of topics related to viral infections, immunology, and drug reactions. Notable papers include:

Independent infections of porcine deltacoronavirus among Haitian children, 2021, published in Nature
Identification of antiviral antihistamines for COVID-19 repurposing, 2020, published in Biochemical and Biophysical Research Communications
Asah2 Represses the p53-Hmox1 Axis to Protect Myeloid-Derived Suppressor Cells from Ferroptosis, 2021, published in The Journal of Immunology
Emergence of porcine delta-coronavirus pathogenic infections among children in Haiti through independent zoonoses and convergent evolution, 2021, published in bioRxiv (Cold Spring Harbor Laboratory)
Human Leukocyte Antigen B*14:01 and B*35:01 Are Associated With Trimethoprim-Sulfamethoxazole Induced Liver Injury, 2020, published in Hepatology

Frequent co-authors with whom David A. Ostrov has collaborated extensively include:

Danmeng Li
Marco Salemi
Cuong Q. Nguyen
Massimiliano S. Tagliamonte
Carla Mavian

Their work is regularly published in several scientific venues, with multiple publications in:

bioRxiv (Cold Spring Harbor Laboratory)
The Journal of Immunology
Biochemical and Biophysical Research Communications
PLoS ONE
International Journal of Molecular Sciences

The main topics of David A. Ostrov's research are related to:

SARS-CoV-2 and COVID-19 Research
Viral gastroenteritis research and epidemiology
Drug-Induced Adverse Reactions
Animal Virus Infections Studies
COVID-19 Clinical Research Studies
Salivary Gland Disorders and Functions
Urticaria and Related Conditions

Best Publications

Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire

David A. Ostrov;Barry J. Grant;Yuri A. Pompeu;John Sidney

481
Citations
Independent infections of porcine deltacoronavirus among Haitian children.

John A. Lednicky;Massimiliano S. Tagliamonte;Sarah K. White;Maha A. Elbadry

402
Citations
Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension.

Anderson J. Ferreira;Vinayak Shenoy;Yoriko Yamazato;Srinivas Sriramula

319
Citations
Structure-Based Identification of Small-Molecule Angiotensin-Converting Enzyme 2 Activators as Novel Antihypertensive Agents

José A. Hernández Prada;Anderson J. Ferreira;Michael J. Katovich;Vinayak Shenoy

305
Citations
A small molecule inhibitor, 1,2,4,5-benzenetetraamine tetrahydrochloride, targeting the y397 site of focal adhesion kinase decreases tumor growth.

Vita M. Golubovskaya;Carl Nyberg;Min Zheng;Frederick Kweh

255
Citations
A novel ATG4B antagonist inhibits autophagy and has a negative impact on osteosarcoma tumors

Debra Akin;S. Keisin Wang;Pouran Habibzadegah-Tari;Brian Law

242
Citations
Discovery of Novel DNA Gyrase Inhibitors by High-Throughput Virtual Screening

David A. Ostrov;José A. Hernández Prada;Patrick E. Corsino;Kathryn A. Finton

242
Citations
Structure of murine CTLA-4 and its role in modulating T cell responsiveness.

David A. Ostrov;Wuxian Shi;Jean-Claude D. Schwartz;Steven C. Almo

207
Citations
Structure-Based Discovery of a Novel Angiotensin-Converting Enzyme 2 Inhibitor

Matthew J. Huentelman;Jasenka Zubcevic;Jose A. Hernández Prada;Xiaodong Xiao

205
Citations
A novel small molecule inhibitor of FAK decreases growth of human pancreatic cancer.

Steven N. Hochwald;Carl Nyberg;Min Zheng;Donghang Zheng

171
Citations
HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms.

Katherine C. Konvinse;Jason A. Trubiano;Jason A. Trubiano;Rebecca Pavlos;Ian James

167
Citations
Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells

Ashley T. Martino;Etiena Basner-Tschakarjan;David M. Markusic;Jonathan D. Finn

163
Citations
SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation

Katie D. White;Riichiro Abe;Michael Ardern-Jones;Thomas Beachkofsky

159
Citations
Minocycline hepatotoxicity: Clinical characterization and identification of HLA- B*35:02 as a risk factor

Thomas Jacob Urban;Thomas Jacob Urban;Paola Nicoletti;Naga Chalasani;Jose Serrano

152
Citations
Prediction of off-target effects on angiotensin-converting enzyme 2.

Lidia V. Kulemina;David A. Ostrov

146
Citations
T Cell–Mediated Hypersensitivity Reactions to Drugs

Rebecca Pavlos;Simon Mallal;David Ostrov;Soren Buus

141
Citations
Intracellular MLCK1 diversion reverses barrier loss to restore mucosal homeostasis

W Vallen Graham;W Vallen Graham;Weiqi He;Weiqi He;Amanda M Marchiando;Juanmin Zha;Juanmin Zha

138
Citations
Islet autoantigens: Structure, function, localization, and regulation

Peter Arvan;Massimo Pietropaolo;David Ostrov;Christopher J. Rhodes

115
Citations
Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.

Rebecca Pavlos;Simon Mallal;David Ostrov;Yuri Pompeu

112
Citations
Resolution of the novel immune-type receptor gene cluster in zebrafish

Jeffrey A. Yoder;Ronda T. Litman;M. Gail Mueller;Salil Desai

108
Citations